All News

Researchers developing a degradable ureteral stent report progress with their project that supports moving forward into clinical trials.

Stone burden, a non-modifiable factor, was the only independent predictor associated with cost for PCNL.

Several approaches have been taken to attenuate lower urinary tract symptoms and improve quality of life in the stented patient.

"The minute you start letting patients go down that path, where they're using e-mail to communicate, they'll take advantage of it."

Two monoclonal antibodies have demonstrated antitumor activity in clinical trials of men with castrate-resistant prostate cancer.

Percutaneous nephrolithotomy, with or without a tube, offers a high success rate in treating small or asymptomatic lower-pole stones.

Results of a prospective study in which urologic surgeons at Columbia University Medical Center, New York, compared flexible fiber optic and digital cystoscopes show that with proper care, both types are durable for in-office applications.

Treatment for pregnant women who present with renal or ureteral colic may have become easier for physician and patient alike.

Researchers are further exploring the diagnostic and prognostic utility of PCA3, and data showed that combining PCA3 with free PSA and other risk factors significantly improves the accuracy for predicting biopsy outcomes.

Because, as one urologist observed, "we spend more time with our partners than with our families," the importance of finding qualified urologists whose professional and personal styles are compatible with the colleagues in the practice is paramount.

Men with even mild lower urinary tract symptoms are at an increased risk of developing components of cardiometabolic disorders.

Use of magnetic anchoring guidance systems to facilitate single-port and natural orifice surgery yielded success in human subjects.

Laparoscopic partial nephrectomy without collection system suturing led to a urine-leak rate comparable to that of procedures with formal collection-system closure.

Information on new products from Endo Pharmaceuticals, Envisionier Medical Technologies, biolitec, Inc., and Mission Pharmacal.

A new noninvasive vacuum protocol for erectile dysfunction patients using an inflatible penile prosthesis can prevent penile shortening.

Major complications detected by computed tomography performed immediately following percutaneous nephrolithotomy are uncommon. However, certain major complications can be detected early.

Endo Pharmaceuticals has announced the reintroduction of valrubicin (VALSTAR) intravesical therapy for the treatment of Bacillus Calmette-Guérin (BCG)-refractory carcinoma in situ (CIS) of the bladder for whom immediate removal of the bladder would be associated with unacceptable medical risks.

A minimally invasive form of nerve stimulation appears to be an effective alternative to drug therapy in patients with overactive bladder, study results show.

Children on the high-fat ketogenic diet to control epileptic seizures can prevent the kidney stones caused by the diet if they take a daily supplement of potassium citrate (Polycitra K), according to research from Johns Hopkins Children?s Center, Baltimore.

Body mass in younger and older adulthood, and weight gain between these periods, may influence a man?s risk for prostate cancer, and the risk varies among different ethnic populations, report researchers from the University of Hawaii, Honolulu.

Researchers have reported that a virus known to cause leukemia and sarcomas in animals has been found in malignant human prostate cancer cells.

A comparison of outcomes of different eras of conservative treatment for localized prostate cancer indicates that overall and prostate cancer-specific survival rates are higher for men diagnosed from 1992 to 2002 compared with men diagnosed in the 1970s and 1980s.

Men with coronary artery disease-induced congestive heart failure or heart attack who receive hormone therapy before or with radiation therapy for treatment of prostate cancer have an associated increased risk of death, according to researchers at Brigham & Women's Hospital-Dana Farber Cancer Institute, Boston.

EDAP TMS SA has received FDA clearance to market its newly designed Sonolith I-Sys lithotripter in the United States.

In high-risk men, PSA testing performs optimally when conducted intelligently and combined with prompt, effective, high-quality treatment, according to updated clinical practice guidelines on early detection of prostate cancer from the National Comprehensive Cancer Network.

Obesity plays no favorites when it comes to increasing the risk of prostate cancer recurrence after surgery, according to researchers at Duke University Medical Center, Durham, NC. Being overweight is equally bad for African-American and white men.

Since its introduction in 1986, PSA screening has resulted in more than one million men being needlessly diagnosed and treated for prostate cancer, according to a study published online Aug. 31 in the Journal of the National Cancer Institute.

Men with coronary artery disease-induced congestive heart failure or heart attack who receive hormone therapy before or with radiation therapy for treatment of prostate cancer have an associated increased risk of death, according to researchers at Brigham & Women's Hospital-Dana Farber Cancer Institute, Boston.